Fortis Memorial Research Institute, Gurugram unveils Gamma Knife Esprit

The Gamma Knife employs computer-guided precision to target brain tumours without actual cutting, making it an optimal choice for treating both malignant and benign tumours Fortis Memorial Research Institute has launched South Asia's First Gamma Knife Esprit. The groundbreaking version of the Leksell Gamma Knife heralds a new era in the non-surgical high-precision treatment of brain tumours, greatly enhancing therapeutic options for both malignant and benign brain tumours and other abnormalities of the brain. The Gamma Knife employs computer-guided precision to target brain tumours without actual cutting, making it an optimal choice for treating both malignant and benign tumours, including multiple brain metastases, meningiomas, acoustic tumours, and pituitary adenomas. Its precision is crucial for tumours in sensitive or hard-to-reach brain areas sparing healthy brain tissues and allowing patients to return to daily activities almost immediately. Further, radiation therapy for multiple brain metastasis requires almost 30 sessions, in contrast, Gamma Knife radiosurgery consolidates the entire treatment into a single session with same-day discharge, making the treatment swift and efficient. Additionally, Gamma Knife can treat multiple metastasis in a single session irrespective of metastatic lesions involved, a benefit not offered by other technologies. This method significantly minimises radiation exposure to healthy tissues, preserving motor, sensory nerve and neurocognitive function enabling rapid recovery and improved healthy quality of life after treatment. Thus, Gamma Knife radiosurgery is considered as the gold standard for brain radiosurgery worldwide. The procedure can be performed using either frame-based or frameless methods, for personalized care for the patients with a comfortable treatment experience and is followed by stereotactic MRI to ensure precise treatment delivery. Fortis Healthcare has introduced Gamma Knife technology, a time-tested, reliable method with extensive clinical validation and high confidence among clinicians and patients across India and worldwide. This integrated and efficient system boasts a guaranteed accuracy of 0.3 mm, delivering doses to healthy brain tissue that are 2–4x lower than other technologies, with 2–21x lower extracranial doses. This highest accuracy and precision in Gamma knife reduce toxicities and side effects to normal brain. Dr Sandeep Vaishya, Director Neurosurgery, Fortis Gurgaon, said, "The launch of South Asia's first Gamma Knife Esprit at our facility marks a significant milestone in the field of neurosurgery. This advanced technology brings a level of precision to neurosurgical procedures that was previously unattainable, targeting brain tumours with pinpoint accuracy. The Gamma Knife Esprit minimises the radiation exposure to healthy tissues which is crucial for reducing potential side effects. This capability allows us to enhance patient safety and comfort significantly, thus optimising the recovery process. By drastically cutting down recovery times, we are not only improving clinical outcomes but also enhancing the overall patient experience. This is a step forward in our ongoing effort to push the boundaries of what's possible in medical treatment and patient care." Anil Vinayak, Group COO, Fortis Healthcare, elaborated on the broader vision of Fortis as a leader in comprehensive cancer care: "Deploying the first Gamma Knife Esprit in South Asia is a testament to Fortis Healthcare's commitment in integrating cutting-edge technologies in neurosurgery and holistic cancer care. Our commitment extends beyond just offering advanced treatments; it encompasses providing comprehensive care that enhances the overall patient journey and outcomes. This initiative is another step in reinforcing our position at the forefront of medical innovation and patient-centric care across the region." Jan Thesleff, Amabassador of Sweden to India, said, "As the Chief Guest at the launch of the most advanced Gamma Knife Esprit at Fortis Memorial Research Institute (FMRI) in Gurgaon, I am deeply honoured to witness the pioneering collaboration between Swedish companies like Elekta and India’s leading healthcare chain, Fortis Healthcare. This landmark introduction of precision radiosurgery technology, the first of its kind in South Asia, underscores the transformative impact of our partnership and FMRI's dedication to advancing healthcare excellence. Swedish companies are renowned for their leadership in healthcare innovation, and through initiatives like this, we are collectively bridging gaps in advanced medical treatments, ensuring patients in the region have access to cutting-edge care. Our continued collaboration between Sweden and India, particularly with Fortis Healthcare, is a testament to our shared commitment to innovation and excellence in healthcare. I eagerly anticipate the continued success of our partnerships and the delivery of sustainable healthcare solutions for all."